| Neurobiology of cocaine abuse WL Woolverton, KM Johnson Trends in pharmacological sciences 13, 193-200, 1992 | 469 | 1992 |
| Noncompetitive excitatory amino acid receptor antagonists D Lodge, KM Johnson Trends in pharmacological sciences 11 (2), 81-86, 1990 | 462 | 1990 |
| Nitric oxide induces neurotransmitter release from hippocampal slices G Lonart, J Wang, KM Johnson European journal of pharmacology 220 (2-3), 271-272, 1992 | 342 | 1992 |
| Long-term behavioral and neurodegenerative effects of perinatal phencyclidine administration: implications for schizophrenia C Wang, J McInnis, M Ross-Sanchez, P Shinnick-Gallagher, JL Wiley, ... Neuroscience 107 (4), 535-550, 2001 | 293 | 2001 |
| Neuropharmacology of phencyclidine: basic mechanisms and therapeutic potential KM Johnson, SM Jones Annual review of pharmacology and toxicology 30 (1), 707-750, 1990 | 230 | 1990 |
| Characterization of the inhibition of excitatory amino acid-induced neurotransmitter release in the rat striatum by phencyclidine-like drugs. LD Snell, KM Johnson Journal of Pharmacology and Experimental Therapeutics 238 (3), 938-946, 1986 | 220 | 1986 |
| Phencyclidine selectively inhibits N-methyl-D-aspartate-induced hippocampal [3H] norepinephrine release. SM Jones, LD Snell, KM Johnson Journal of Pharmacology and Experimental Therapeutics 240 (2), 492-497, 1987 | 190 | 1987 |
| Nitric oxide induces calcium‐dependent release of [3H] dopamine release from striatal slices G Lonart, KL Cassels, KM Johnson Journal of neuroscience research 35 (2), 192-198, 1993 | 168 | 1993 |
| Postnatal phencyclidine administration selectively reduces adult cortical parvalbumin-containing interneurons CZ Wang, SF Yang, Y Xia, KM Johnson Neuropsychopharmacology 33 (10), 2442-2455, 2008 | 160 | 2008 |
| Inhibitory Effects of Nitric Oxide on the Uptake of [3H]Dopamine and [3H]Glutamate by Striatal Synaptosomes G Lonart, KM Johnson Journal of neurochemistry 63 (6), 2108-2117, 1994 | 158 | 1994 |
| Antagonism of N-methyl-D-aspartate-induced transmitter release in the rat striatum by phencyclidine-like drugs and its relationship to turning behavior. LD Snell, KM Johnson Journal of Pharmacology and Experimental Therapeutics 235 (1), 50-57, 1985 | 158 | 1985 |
| Pharmacophore-based discovery of substituted pyridines as novel dopamine transporter inhibitors IJ Enyedy, S Sakamuri, WA Zaman, KM Johnson, S Wang Bioorganic & Medicinal Chemistry Letters 13 (3), 513-517, 2003 | 143 | 2003 |
| Comparison of the effects of MK-801 and phencyclidine on catecholamine uptake and NMDA-induced norepinephrine release LD Snell, SJ Yi, KM Johnson European journal of pharmacology 145 (2), 223-226, 1988 | 135 | 1988 |
| Mechanism of action of rab3A in mossy fiber LTP G Lonart, R Janz, KM Johnson, TC Südhof Neuron 21 (5), 1141-1150, 1998 | 130 | 1998 |
| Glycine potentiates N-methyl-D-aspartate-induced [3H] TCP binding to rat cortical membranes LD Snell, RS Morter, KM Johnson Neuroscience letters 83 (3), 313-317, 1987 | 128 | 1987 |
| Structural requirements for activation of the glycine receptor that modulates the N-methyl-D-aspartate operated ion channel LD Snell, RS Morter, KM Johnson European journal of pharmacology 156 (1), 105-110, 1988 | 126 | 1988 |
| Spermine enhances binding to the glycine site associated with the N-methyl-D-aspartate receptor complex. AI Sacaan, KM Johnson Molecular pharmacology 36 (6), 836-839, 1989 | 116 | 1989 |
| Blockade of phencyclidine-induced cortical apoptosis and deficits in prepulse inhibition by M40403, a superoxide dismutase mimetic C Wang, J McInnis, JB West, J Bao, N Anastasio, JA Guidry, Y Ye, ... Journal of Pharmacology and Experimental Therapeutics 304 (1), 266-271, 2003 | 115 | 2003 |
| Inhibition by phencyclidine of excitatory amino acid-stimulated release of neurotransmitter in the nucleus accumbens SM Jones, LD Snell, KM Johnson Neuropharmacology 26 (2-3), 173-179, 1987 | 111 | 1987 |
| Mechanisms ofN-Methyl-d-aspartate-Induced Apoptosis in Phencyclidine-Treated Cultured Forebrain Neurons C Wang, JA Kaufmann, MG Sanchez-Ross, KM Johnson Journal of Pharmacology and Experimental Therapeutics 294 (1), 287-295, 2000 | 110 | 2000 |
Gyorgy LonartEastern Virginia Medical SchoolVerified email at evms.edu
